GENE ONLINE|News &
Opinion
Blog

M&A
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
Bristol Myers Squibb Acquires Cancer Cell Therapy Partner 2seventy Bio in $286M Deal
2025-03-12
The Stargate Project: A $500 Billion Initiative that Will Bring Tech Giants to the AI Table
2025-01-24
Neuro, Pain, and Cancer Top the List at JPM 2025 Healthcare Conference
2025-01-17
EY Predicts Smarter, Smaller M&A in Biotech and Pharma for 2025
2025-01-15
The Boldest Business Matchmaking of 2024: A Look at the Top M&A Activity
2025-01-02
Novo Nordisk Invests $1.2 Billion in New Denmark Factory, Fresh Off Catalent Deal
2024-12-17
Novartis Invests $745M to Compete with BMS and Lilly in the Radiopharma Race
2024-11-19
Big Pharma’s Next Move: BMS, Merck, Amgen Eye M&A to Tackle Patent Expirations
2024-11-14
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Vertex Pharmaceuticals Makes $4.9 Billion Bet on Kidney Disease Treatment through Alpine Immune Acquisition
2024-04-11
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
AstraZeneca’s Latest Moves in Pharmaceuticals in Q1 2024
2024-03-21
GSK Completed the Acquisition of Aiolos Bio, Enhancing the Respiratory Portfolio of Asthma
2024-02-16
Gilead Sciences Acquires CymaBay for $4.3 billion, Heralding a New Era in PBC Treatment
2024-02-15
1 2 3 14
LATEST
Comparative Analysis of Tirzepatide (Zepbound/Mounjaro) and Semaglutide (Wegovy) for Weight Loss
2025-05-12
Donald Trump’s “Most Favored Nation” Executive Order on Drug Pricing
2025-05-12
Discover Investment Opportunities & Innovation at International Healthcare Week in Hong Kong from May
2025-05-12
The Buffett Paradox: Cola, Happiness, and a Biotech Longevity Enigma
2025-05-11
President to Sign Executive Order on Trade Enforcement Monday Morning
2025-05-11
Trump to Sign Executive Order Linking U.S. Drug Prices to International Levels.
2025-05-11
Podcast Highlights Agile Biopharmaceutical Firms’ Strategies for Navigating Complex Clinical Trials
2025-05-11
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top